OppenheimerFunds’s Ionis Pharmaceuticals IONS Stock Holding History

OppenheimerFunds’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$165M	Buy	2,027,449 +7,323	+0.4%	+$472K	0.2%	113
2018 Q4	$109M	Sell	2,020,126 -47,474	-2%	-$2.42M	0.16%	142
2018 Q3	$107M	Sell	2,067,600 -864,450	-29%	-$40.6M	0.12%	183
2018 Q2	$122M	Buy	2,932,050 +57,025	+2%	+$2.53M	0.15%	166
2018 Q1	$127M	Buy	2,875,025 +185,044	+7%	+$9.4M	0.16%	152
2017 Q4	$135M	Sell	2,689,981 -18,426	-0.7%	-$1.01M	0.16%	153
2017 Q3	$137M	Sell	2,708,407 -25,111	-0.9%	-$1.32M	0.17%	145
2017 Q2	$139M	Buy	2,733,518 +10,418	+0.4%	+$485K	0.17%	152
2017 Q1	$109M	Sell	2,723,100 -406	-0%	-$18.2K	0.13%	177
2016 Q4	$130M	Buy	2,723,506 +529,880	+24%	+$21M	0.16%	155
2016 Q3	$80.4M	Buy	2,193,626 +307,175	+16%	+$9.61M	0.1%	233
2016 Q2	$43.9M	Buy	1,886,451 +437,260	+30%	+$14.1M	0.06%	344
2016 Q1	$58.7M	Buy	1,449,191 +178,870	+14%	+$7.27M	0.08%	272
2015 Q4	$78.7M	Buy	+1,270,321	New	+$68.5M	0.1%	221

Other funds holding IONS

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

First Trust Advisors

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return